To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MAL2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
483 supporting clones for gene MAL2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP237136 coronary artery .a 1 to 581 1 to 581 L81X tiling clone,   581/583
(99 %)
3 diff
(99.5 %id)
DA881692   .a 1 to 547 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA160948 amygdala .b 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DA152990 amygdala .c 1 to 573 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
DA764207 tongue .c 252 to 840 2 to 590 exact capped   589/589
(100 %)
0 diff
(100 %id)
DA828429 placenta .c 274 to 891 2 to 621 exact tiling clone, capped   620/620
(100 %)
5 diff
(99.2 %id)
CV571548 cornea, eye .c 280 to 843 1 to 564 exact tiling clone,   564/564
(100 %)
0 diff
(100 %id)
DB372950 placenta .c 2415 to 2914 507 to 1   tiling clone,   507/514
(98 %)
26 diff
(95.0 %id)
DA749058   .d 1 to 572 2 to 573 exact tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
TI_1948099316   .d 135 to 540 518 to 112 exact     407/1278
(31 %)
12 diff
(99.1 %id)
TI_1948099157   .d 156 to 540 507 to 120 F2C V3L S4C V5P T6*     388/1389
(27 %)
14 diff
(99.0 %id)
BG979314 colon_normal .d 177 to 498 1 to 321       321/321
(100 %)
8 diff
(97.6 %id)
AA292157 ovarian tumor, ovary .d 346 to 441 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
BC012367 Ovary, adenocarcinoma .e -9 to 923 1 to 932 exact tiling clone, available from MGC, AAA   932/932
(100 %)
1 diff
(99.9 %id)
NM_052886.2   .e -9 to 2807 1 to 2816 exact RefSeq, AAA   2816/2816
(100 %)
1 diff
(100.0 %id)
CV574204 cornea, eye .e -9 to 616 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
CR735396 lymph, lymphoma, cell line .e 1 to 502 44 to 544       506/544
(93 %)
6 diff
(98.9 %id)
DB482180.
matches multiple genes
hippocampus .e 1 to 473 4 to 475     also hits gene sporbla 475/475
(100 %)
2 diff
(99.6 %id)
BM928482 hepatocellular carcinoma, cell line, Liver .e 1 to 632 3 to 633 exact available from MGC,   633/1095
(57 %)
6 diff
(99.5 %id)
BQ064576 lymph, lymphoma, cell line .e 1 to 632 3 to 633 exact     633/1037
(61 %)
6 diff
(99.5 %id)
BQ647271 hepatocellular carcinoma, cell line, Liver .e 1 to 631 3 to 634 G69R Q70A P71A L72T L73P ...     634/907
(69 %)
14 diff
(98.5 %id)
BQ652699 hepatocellular carcinoma, cell line, Liver .e 1 to 632 3 to 633 exact     633/934
(67 %)
6 diff
(99.4 %id)
BQ654249 hepatocellular carcinoma, cell line, Liver .e 1 to 632 3 to 634 L101S A102G L103F R104T R105K ...     634/951
(66 %)
8 diff
(99.2 %id)
BQ652468 hepatocellular carcinoma, cell line, Liver .e 1 to 615 3 to 623       623/1042
(59 %)
13 diff
(98.8 %id)
BQ646250 hepatocellular carcinoma, cell line, Liver .e 1 to 605 3 to 612       608/915
(66 %)
14 diff
(98.5 %id)
BQ644958 hepatocellular carcinoma, cell line, Liver .e 1 to 629 3 to 631 N81T R104P R105K W106M R107G ...     631/975
(64 %)
12 diff
(98.8 %id)
BQ648164 hepatocellular carcinoma, cell line, Liver .e 1 to 551 3 to 552       552/1019
(54 %)
3 diff
(99.8 %id)
DA389458 thalamus .e 1 to 581 2 to 580   capped   579/579
(100 %)
4 diff
(99.4 %id)
DN995653 breast cancer, Mammary gland (cancer tissue) .e 8 to 722 1 to 714 exact     714/714
(100 %)
4 diff
(99.5 %id)
AY007723   .e 14 to 2807 1 to 2793 exact tiling clone, AAA   2793/2793
(100 %)
1 diff
(100.0 %id)
AW630088 2 pooled high-grade transitional celltumors, genitourinary tract .e 29 to 489 1 to 460       460/463
(99 %)
10 diff
(97.9 %id)
CN402165 embryonic stem cells, DMSO-treated H9 cellline .e 32 to 347 1 to 315       315/315
(100 %)
1 diff
(99.7 %id)
CF995154 Human Placenta, placenta .e 54 to 771 28 to 752 exact     725/866
(83 %)
19 diff
(97.9 %id)
BX441729 brain, fetal brain .e 66 to 944 1 to 876 exact     876/876
(100 %)
8 diff
(99.1 %id)
DA267133 caudate nucleus .e 70 to 624 2 to 555 M90T capped   554/554
(100 %)
3 diff
(99.5 %id)
DA437870 tongue, tumor tissue .e 72 to 628 2 to 558 exact capped   557/557
(100 %)
3 diff
(99.5 %id)
DA788270 brain .e 72 to 633 2 to 563 exact capped   562/562
(100 %)
4 diff
(99.3 %id)
BP243687 Liver .e 75 to 649 1 to 574 exact     574/574
(100 %)
3 diff
(99.5 %id)
DA791680 brain .e 79 to 605 2 to 527   capped   526/529
(99 %)
2 diff
(99.7 %id)
DB478085.
matches multiple genes
hippocampus .e 81 to 577 1 to 496     also hits gene sporbla 496/496
(100 %)
2 diff
(99.6 %id)
AK312030 brain .e 84 to 624 1 to 540 exact     540/540
(100 %)
2 diff
(99.7 %id)
DA489257 brain .e 85 to 637 2 to 553 exact capped   552/552
(100 %)
1 diff
(99.9 %id)
TI_1948099466   .e 91 to 621 126 to 656       531/716
(74 %)
12 diff
(98.4 %id)
CV023605 mixed .e 93 to 632 1 to 539 exact     539/659
(81 %)
6 diff
(99.1 %id)
CD359184 testis .e 102 to 862 12 to 783 exact     772/929
(83 %)
29 diff
(96.9 %id)
TI_1948099015   .e 170 to 632 580 to 118 exact     463/1302
(35 %)
17 diff
(98.7 %id)
BE870717 adenocarcinoma, colon .e 234 to 982 1 to 746 F35L A36P Y37T H38I F39L ...     746/816
(91 %)
21 diff
(97.5 %id)
BM142380 Islets of Langerhans, Pancreas .e 260 to 427 1 to 168   fully sequenced,   168/168
(100 %)
0 diff
(100 %id)
H09290 whole brain .e 262 to 747 1 to 498 L101S A102G R104Y R105G W106R ...     498/498
(100 %)
18 diff
(96.4 %id)
BI918469 brain .e 273 to 817 27 to 566 F2L V3C S4H V5D T6S ...     540/566
(95 %)
7 diff
(98.8 %id)
TI_57238573   .e 273 to 817 27 to 566 F2L V3C S4H V5D T6S ...     540/566
(95 %)
7 diff
(98.8 %id)
DA738236   .e 324 to 1118 2 to 793   capped   792/796
(99 %)
7 diff
(99.2 %id)
DA920590 small intestine .e 328 to 883 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA920596 small intestine .e 328 to 890 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BM142556 Islets of Langerhans, Pancreas .e 368 to 929 563 to 2   fully sequenced,   562/563
(99 %)
0 diff
(100 %id)
DB192604 ovary, tumor tissue .e 372 to 887 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
BP360458 thalamus .e 375 to 956 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BE868290 adenocarcinoma, colon .e 388 to 1008 1 to 640       640/1050
(60 %)
57 diff
(94.6 %id)
BM797888 Ascites, stomach .e 390 to 790 5 to 405       401/405
(99 %)
6 diff
(98.6 %id)
AA806214 epithelium (cell line), Prostate .e 396 to 929 536 to 3       534/556
(96 %)
8 diff
(98.6 %id)
DA201362 brain .e 402 to 931 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA303039 hippocampus .e 412 to 990 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CN402161 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 418 to 1225 1 to 809       809/809
(100 %)
1 diff
(99.9 %id)
BP352130   .e 421 to 997 1 to 580       580/580
(100 %)
5 diff
(99.2 %id)
AA427513 ovarian tumor, ovary .e 438 to 924 1 to 487   fully sequenced,   487/487
(100 %)
0 diff
(100 %id)
BM768711 stomach .e 443 to 929 1 to 487       487/487
(100 %)
0 diff
(100 %id)
DB011200 colon, tumor tissue .e 443 to 1008 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BG291022 bladder, transitional cell papilloma, cell line .e 450 to 1119 1 to 672       670/1182
(56 %)
17 diff
(98.6 %id)
CN402166 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 453 to 1146 1 to 694       694/694
(100 %)
0 diff
(100 %id)
AI904853 breast .e 455 to 909 25 to 478       454/478
(94 %)
7 diff
(98.6 %id)
AA126879 lung, lung carcinoma .e 489 to 894 1 to 406     Submitted on the opposite strand 406/406
(100 %)
0 diff
(100 %id)
AI910856 pooled .e 495 to 996 512 to 12   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 501/501
(100 %)
4 diff
(99.3 %id)
CN402164 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 499 to 1153 1 to 655       655/655
(100 %)
5 diff
(99.3 %id)
AW015950   .e 516 to 828 331 to 19   AAA   313/313
(100 %)
0 diff
(100 %id)
AA134019 lung, lung carcinoma .e 518 to 899 382 to 1     Submitted on the opposite strand 382/382
(100 %)
0 diff
(100 %id)
AI904879 breast .e 526 to 995 476 to 8       469/476
(98 %)
2 diff
(99.6 %id)
BE539894 cervix .e 531 to 1157 1 to 648       648/798
(81 %)
17 diff
(97.9 %id)
DA308864 hippocampus .e 561 to 1136 2 to 573   capped   572/572
(100 %)
6 diff
(99.0 %id)
BF431148 Kidney .e 561 to 923 365 to 1       365/365
(100 %)
2 diff
(99.5 %id)
BE148648 head_neck .e 585 to 696 1 to 113       113/113
(100 %)
2 diff
(98.3 %id)
CV571948 cornea, eye .e 607 to 1191 1 to 585       585/585
(100 %)
0 diff
(100 %id)
DB265962 uterus .e 652 to 1220 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BP291623 lung .e 660 to 1242 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP352497   .e 670 to 1249 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
AI766506 colon, colon tumor, RER+ .e 675 to 923 269 to 21   AAA   249/249
(100 %)
4 diff
(98.4 %id)
CN402160 embryonic stem cells, DMSO-treated H9 cellline .e 692 to 923 1 to 232   AAA   232/232
(100 %)
3 diff
(98.8 %id)
BM763944 myeloma .e 692 to 1417 1 to 726       726/726
(100 %)
0 diff
(100 %id)
AL117612 brain .e 701 to 2805 1 to 2105   available from DKFZ, AAA   2105/2105
(100 %)
4 diff
(99.9 %id)
DA381118 thalamus .e 701 to 1249 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BP221122 colon .e 746 to 1311 1 to 566       566/566
(100 %)
5 diff
(99.2 %id)
BG290165 bladder, transitional cell papilloma, cell line .e 747 to 1518 1 to 759       759/765
(99 %)
21 diff
(97.3 %id)
BG036684 adenocarcinoma, cell line, Prostate .e 763 to 1501 1 to 735       735/977
(75 %)
36 diff
(96.4 %id)
BF038191 adenocarcinoma, ovary .e 765 to 1502 1 to 727       727/923
(78 %)
25 diff
(97.3 %id)
BG180137 adenocarcinoma, cell line, Prostate .e 792 to 1582 1 to 793       793/822
(96 %)
30 diff
(96.4 %id)
BX451526 brain, fetal brain .e 793 to 1733 1 to 949       949/949
(100 %)
10 diff
(99.0 %id)
DA712284   .e 795 to 1347 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA158855 amygdala .e 796 to 1365 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
BE538582 cervix .e 796 to 1361 1 to 568       568/568
(100 %)
15 diff
(97.4 %id)
BP309930 brain .e 798 to 1380 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DB245799 uterus, tumor tissue .e 798 to 1372 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA056427 cerebellum .e 803 to 1401 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
AA430722 ovarian tumor, ovary .e 808 to 931 124 to 1   fully sequenced,   124/124
(100 %)
0 diff
(100 %id)
BP220080 colon .e 821 to 1397 1 to 577       577/577
(100 %)
6 diff
(99.0 %id)
BP220108 colon .e 821 to 1395 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
DA356187 subthalamic nucleus .e 822 to 1372 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BM785983 Ascites, stomach .e 830 to 1434 1 to 605       605/605
(100 %)
0 diff
(100 %id)
DA811816 ovary, tumor tissue .e 831 to 1600 2 to 769   capped   768/768
(100 %)
4 diff
(99.5 %id)
AA453210   .e 836 to 1276 1 to 442       442/442
(100 %)
6 diff
(98.7 %id)
BM829212 Ascites, stomach .e 858 to 1444 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BP221009 colon .e 859 to 1437 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
BP277077 Kidney .e 863 to 1447 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BE873193 adenocarcinoma, colon .e 867 to 1478 1 to 614       614/884
(69 %)
7 diff
(99.3 %id)
DA832172 placenta .e 878 to 1562 2 to 690   capped   689/755
(91 %)
10 diff
(98.7 %id)
DB203087 trachea .e 880 to 1456 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
F12752 brain, total brain .e 888 to 1218 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
T74962 whole brain .e 890 to 1318 1 to 439       439/452
(97 %)
16 diff
(96.5 %id)
BG261034 bladder, transitional cell papilloma, cell line .e 897 to 1613 1 to 714       714/868
(82 %)
11 diff
(98.8 %id)
BE868654 adenocarcinoma, colon .e 904 to 1471 1 to 594       594/1020
(58 %)
48 diff
(95.3 %id)
BE537632 cervix .e 914 to 1523 5 to 616       612/616
(99 %)
20 diff
(96.8 %id)
DA811773 ovary, tumor tissue .e 914 to 1665 2 to 753   capped   752/752
(100 %)
4 diff
(99.5 %id)
DA832568 placenta .e 914 to 1575 2 to 665   capped   664/665
(99 %)
9 diff
(98.7 %id)
BM752173 Ascites, stomach .e 932 to 1381 1 to 451       451/451
(100 %)
1 diff
(99.8 %id)
F06590 brain, total brain .e 957 to 1320 1 to 364       364/364
(100 %)
1 diff
(99.8 %id)
R14640 whole brain .e 958 to 1309 1 to 360       360/432
(83 %)
9 diff
(98.0 %id)
BE697942 colon .e 963 to 1292 1 to 330       330/330
(100 %)
8 diff
(97.6 %id)
DA090238 cerebellum .e 966 to 1538 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB194061 ovary, tumor tissue .e 969 to 1450 2 to 484   capped   483/490
(98 %)
3 diff
(99.4 %id)
DB009420 colon, tumor tissue .e 975 to 1550 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BM854563 stomach .e 977 to 1496 1 to 519       519/519
(100 %)
1 diff
(99.9 %id)
BQ083029 stomach .e 977 to 1551 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
BM828264 stomach .e 977 to 1556 1 to 579       579/579
(100 %)
14 diff
(97.6 %id)
BM821907 stomach .e 984 to 1537 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
FN131291 breast carcinoma .e 1001 to 1098 100 to 3     Submitted on the opposite strand 98/101
(97 %)
0 diff
(100 %id)
BP262658 small intestine .e 1016 to 1597 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BM783498 stomach .e 1016 to 1729 1 to 715       715/715
(100 %)
1 diff
(99.9 %id)
BG500519 adenocarcinoma, Prostate .e 1017 to 1620 1 to 605       605/605
(100 %)
5 diff
(99.2 %id)
BG499681 adenocarcinoma, Prostate .e 1036 to 1821 1 to 797       797/797
(100 %)
17 diff
(97.9 %id)
BM842303 lymph node, stomach .e 1039 to 1443 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
R15941 whole brain .e 1044 to 1434 1 to 391       391/440
(88 %)
7 diff
(98.5 %id)
BP263246 small intestine .e 1052 to 1619 1 to 570       570/570
(100 %)
5 diff
(99.2 %id)
CB114656 Liver .e 1054 to 1640 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
R56752 whole brain .e 1072 to 1411 1 to 344       344/347
(99 %)
6 diff
(98.3 %id)
CN402163 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1082 to 1820 1 to 739       739/739
(100 %)
1 diff
(99.9 %id)
BP277436 Kidney .e 1088 to 1458 1 to 370       370/567
(65 %)
9 diff
(98.5 %id)
BP261102 small intestine .e 1095 to 1677 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP261534 small intestine .e 1095 to 1674 1 to 580       580/582
(99 %)
6 diff
(99.0 %id)
DB370996 ovary, tumor tissue .e 2255 to 2807 559 to 1       559/560
(99 %)
18 diff
(96.8 %id)
DB378220 placenta .e 2285 to 2807 524 to 1       524/524
(100 %)
13 diff
(97.6 %id)
DB370835   .e 2308 to 2807 500 to 1       500/500
(100 %)
9 diff
(98.2 %id)
DB378821 placenta .e 2308 to 2807 502 to 1       502/502
(100 %)
8 diff
(98.5 %id)
AA451669   .e 2382 to 2807 426 to 1       426/426
(100 %)
0 diff
(100 %id)
H09291 whole brain .e 2398 to 2807 447 to 17   AAA   431/436
(98 %)
29 diff
(93.4 %id)
R56904 whole brain .e 2433 to 2807 411 to 18   AAA   394/397
(99 %)
25 diff
(93.8 %id)
R45622 whole brain .e 2483 to 2809 345 to 8       338/345
(97 %)
0 diff
(100 %id)
R43568 whole brain .e 2569 to 2805 243 to 3       241/243
(99 %)
0 diff
(100 %id)
R15940 whole brain .e 2569 to 2807 256 to 18   AAA   239/239
(100 %)
0 diff
(100 %id)
Z39570 brain, total brain .e 2581 to 2807 227 to 1       227/237
(95 %)
0 diff
(100 %id)
DA090736 cerebellum .f-u 1 to 562 5 to 567   tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
CN402162 embryonic stem cells, DMSO-treated H9 cellline .f-u 11 to 720 1 to 710 exact     710/710
(100 %)
5 diff
(99.3 %id)
BP262435 small intestine .f-u 16 to 585 1 to 570       570/571
(99 %)
4 diff
(99.3 %id)
AA338081 endometrium .f-u 28 to 297 1 to 270       270/270
(100 %)
0 diff
(100 %id)
BQ549964 insulinoma, Pancreas .f-u 48 to 651 1 to 604       604/604
(100 %)
5 diff
(99.2 %id)
CK820328 insulinoma, Pancreas .f-u 48 to 629 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BE566251 bladder, carcinoma, cell line .f-u 50 to 637 1 to 592       592/711
(83 %)
29 diff
(96.0 %id)
BM791451 stomach .f-u 54 to 612 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BM829828 stomach .f-u 54 to 629 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BM830162 stomach .f-u 54 to 721 1 to 668 exact     668/668
(100 %)
0 diff
(100 %id)
BU182980 bone marrow, from acute myelogenous leukemia .f-u 63 to 813 33 to 794 A23S P25F N26Q R27*     762/794
(95 %)
6 diff
(99.3 %id)
BG285642 bladder, transitional cell papilloma, cell line .f-u 68 to 814 1 to 736 exact     736/738
(99 %)
17 diff
(97.7 %id)
BE380025 bladder, carcinoma, cell line .f-u 81 to 823 8 to 737 C21S K33S L35T L36S L37K ...     730/833
(87 %)
6 diff
(99.3 %id)
CV569751 cornea, eye .f-u 87 to 733 1 to 647 exact tiling clone,   647/647
(100 %)
0 diff
(100 %id)
FN122543 breast carcinoma .f-u 107 to 215 111 to 1     Submitted on the opposite strand 111/122
(90 %)
2 diff
(98.4 %id)
BP264404 small intestine .f-u 111 to 691 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM757119 Ascites, stomach .f-u 112 to 627 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
BF036793 adenocarcinoma, ovary .f-u 129 to 892 1 to 759 C17V V18C W19G I20Y C21V ...     759/771
(98 %)
37 diff
(95.3 %id)
BG178811 adenocarcinoma, cell line, Prostate .f-u 133 to 849 1 to 720 K54N L55V     720/1113
(64 %)
19 diff
(98.3 %id)
FN055983 breast carcinoma .f-u 144 to 252 109 to 1     Submitted on the opposite strand 109/109
(100 %)
0 diff
(100 %id)
BM856158 stomach .f-u 153 to 384 1 to 232       232/232
(100 %)
0 diff
(100 %id)
FN176036 breast carcinoma .f-u 161 to 249 1 to 89       89/89
(100 %)
4 diff
(95.6 %id)
BM760744 lymph node, stomach .f-u 192 to 889 1 to 698 exact     698/698
(100 %)
1 diff
(99.9 %id)
BM842313 lymph node, stomach .f-u 192 to 641 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BM843070 lymph node, stomach .f-u 192 to 886 1 to 695 exact     695/695
(100 %)
1 diff
(99.9 %id)
BE928469 colon .f-u 206 to 574 1 to 371       371/374
(99 %)
30 diff
(92.0 %id)
T08550   .f-u 221 to 639 1 to 418       418/419
(99 %)
7 diff
(98.4 %id)
BQ631632 Pancreas, Purified pancreatic islet .f-u 231 to 850 11 to 630 exact     620/630
(98 %)
6 diff
(99.1 %id)
Z45897 brain, total brain .f-u 254 to 552 1 to 299       299/299
(100 %)
0 diff
(100 %id)
CV574807 cornea, eye .f-u 254 to 827 1 to 574 exact     574/574
(100 %)
0 diff
(100 %id)
BG283128 adenocarcinoma, cell line, Prostate .f-u 267 to 1007 1 to 730 exact     730/733
(99 %)
18 diff
(97.6 %id)
CF139072 CNCAP(3)T-225 cell line, Prostate .f-u 271 to 808 1 to 538 exact     538/538
(100 %)
5 diff
(99.1 %id)
FN116671 breast carcinoma .f-u 277 to 352 1 to 76       76/77
(98 %)
3 diff
(96.2 %id)
TI_154169238   .f-u 278 to 865 80 to 667 exact     588/588
(100 %)
0 diff
(100 %id)
T80473 whole brain .f-u 284 to 661 1 to 386       386/420
(91 %)
15 diff
(96.5 %id)
R12350 whole brain .f-u 294 to 682 1 to 404       404/416
(97 %)
20 diff
(95.2 %id)
BM745709 Ascites, stomach .f-u 295 to 892 1 to 597 exact     597/597
(100 %)
2 diff
(99.7 %id)
BQ326283 colon_normal .f-u 308 to 502 1 to 197       197/197
(100 %)
8 diff
(96.0 %id)
R35529 whole brain .f-u 327 to 771 1 to 447 E12G Y13I T14Y H15P I16Y ...     447/543
(82 %)
15 diff
(97.3 %id)
BM763559 myeloma .f-u 329 to 794 1 to 466 exact     466/466
(100 %)
1 diff
(99.8 %id)
CF141352 CNCAP(3)T-225 cell line, Prostate .f-u 331 to 828 1 to 498 exact     498/498
(100 %)
6 diff
(98.8 %id)
TI_154172078   .f-u 338 to 936 78 to 676 exact     599/599
(100 %)
7 diff
(98.9 %id)
BI093388 cervix .f-u 350 to 1178 1 to 832 exact     832/886
(93 %)
22 diff
(97.6 %id)
BU194344 bone marrow, from acute myelogenous leukemia .f-u 351 to 1151 1 to 812 exact     812/815
(99 %)
35 diff
(95.8 %id)
BF243233 bone marrow, from acute myelogenous leukemia .f-u 353 to 1048 1 to 684 L2A Q3S N4E T5Y V6X ...     684/854
(80 %)
44 diff
(94.9 %id)
FN093028 breast carcinoma .f-u 355 to 450 1 to 93       93/96
(96 %)
7 diff
(92.8 %id)
BI010799 lung_normal .f-u 369 to 849 1 to 481 C8G C17G L40W F43L L47W ...     481/481
(100 %)
25 diff
(94.9 %id)
BG255133 adenocarcinoma, cell line, Prostate .f-u 377 to 1096 1 to 716 R31T     716/980
(73 %)
10 diff
(99.0 %id)
BG036667 adenocarcinoma, cell line, Prostate .f-u 413 to 1131 1 to 726 exact     726/983
(73 %)
16 diff
(98.4 %id)
BI850614 adenocarcinoma, cell line, Prostate .f-u 413 to 1059 1 to 646 exact     646/646
(100 %)
2 diff
(99.7 %id)
BE180564 head_neck .f-u 420 to 1069 1 to 647 L40W     647/648
(99 %)
11 diff
(98.4 %id)
CX784922 human embryonic stem cells .f-u 423 to 1145 1 to 723 exact     723/723
(100 %)
0 diff
(100 %id)
FN086271 breast carcinoma .f-u 425 to 489 1 to 66       66/67
(98 %)
2 diff
(97.1 %id)
BM763491 myeloma .f-u 430 to 1001 1 to 571 exact     571/571
(100 %)
2 diff
(99.7 %id)
BM839888 myeloma .f-u 430 to 978 1 to 549 exact     549/549
(100 %)
1 diff
(99.9 %id)
BE548872 cervical carcinoma cell line, cervix .f-u 440 to 588 391 to 543       478/543
(88 %)
43 diff
(92.1 %id)
BF036564 adenocarcinoma, ovary .f-u 455 to 1126 1 to 667 V7F C8A P9L V10C H11M ...     667/932
(71 %)
12 diff
(98.8 %id)
BE870823 adenocarcinoma, colon .f-u 463 to 1223 1 to 748 C17V V18C W19G I20Y C21V ...     748/891
(83 %)
29 diff
(96.8 %id)
CB162964 Liver .f-u 493 to 1091 1 to 600 R30K R31V I32F K33T F34S ...     600/600
(100 %)
3 diff
(99.5 %id)
AA131851 uterus .f-u 538 to 1054 1 to 528 E44X N48D     528/531
(99 %)
20 diff
(96.3 %id)
BE871328 adenocarcinoma, colon .f-u 550 to 1290 1 to 736       736/937
(78 %)
22 diff
(97.7 %id)
BG291872 bladder, transitional cell papilloma, cell line .f-u 557 to 1304 1 to 755       755/771
(97 %)
37 diff
(95.3 %id)
BG292021 bladder, transitional cell papilloma, cell line .f-u 568 to 1318 1 to 752       752/755
(99 %)
19 diff
(97.5 %id)
FN107694 breast carcinoma .f-u 574 to 630 1 to 57       57/58
(98 %)
1 diff
(98.3 %id)
AA315096 colon .f-u 576 to 1105 1 to 532       532/534
(99 %)
4 diff
(99.3 %id)
H84673 eye, retina .f-u 584 to 1034 1 to 461       461/462
(99 %)
18 diff
(96.2 %id)
BQ307966 breast .f-u 585 to 731 1 to 146       146/146
(100 %)
10 diff
(93.2 %id)
BF038357 adenocarcinoma, ovary .f-u 593 to 1390 1 to 788       788/918
(85 %)
45 diff
(95.1 %id)
BM771198 Ascites, stomach .f-u 594 to 1293 1 to 700       700/700
(100 %)
0 diff
(100 %id)
BM771274 Ascites, stomach .f-u 594 to 1125 1 to 532       532/532
(100 %)
0 diff
(100 %id)
BM740009 Ascites, stomach .f-u 601 to 1106 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
BG291510 bladder, transitional cell papilloma, cell line .f-u 604 to 1311 1 to 698       698/699
(99 %)
14 diff
(98.0 %id)
AW748181 breast .f-u 612 to 1098 4 to 489       486/489
(99 %)
6 diff
(98.8 %id)
H93521.
matches multiple genes
liver and spleen .f-u 622 to 947 1 to 326     also hits gene HSPA4 326/335
(97 %)
11 diff
(96.8 %id)
BG282848 adenocarcinoma, cell line, Prostate .f-u 631 to 1279 1 to 653       653/999
(65 %)
10 diff
(99.0 %id)
FN063309 breast carcinoma .f-u 640 to 757 1 to 118       118/118
(100 %)
2 diff
(98.4 %id)
FN141796 breast carcinoma .f-u 644 to 755 1 to 115       115/121
(95 %)
4 diff
(96.7 %id)
BF107388 placenta .f-u 651 to 1290 1 to 632       632/659
(95 %)
33 diff
(95.0 %id)
BI255954 cervical carcinoma cell line, cervix .f-u 654 to 1473 1 to 817       817/817
(100 %)
9 diff
(98.9 %id)
BG426269 Kidney .f-u 657 to 1380 1 to 716       716/840
(85 %)
25 diff
(97.1 %id)
BM831444 stomach .f-u 664 to 1298 1 to 635   tiling clone,   635/635
(100 %)
0 diff
(100 %id)
BP262129 small intestine .f-u 674 to 1255 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CB147948 Liver .f-u 684 to 1183 1 to 499       499/499
(100 %)
5 diff
(99.0 %id)
CB135062 Liver .f-u 689 to 1339 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
BM829113 Ascites, stomach .f-u 693 to 1073 1 to 381       381/381
(100 %)
3 diff
(99.3 %id)
BM798655 myeloma .f-u 695 to 1100 1 to 406       406/406
(100 %)
1 diff
(99.8 %id)
AW674984.
matches multiple genes
cervix .f-u 710 to 1140 1 to 431     also hits gene LDHB 431/431
(100 %)
0 diff
(100 %id)
BF184027 bone marrow, from chronic myelogenous leukemia .f-u 719 to 1257 117 to 656       540/716
(75 %)
6 diff
(99.2 %id)
DR978586 brain .f-u 722 to 861 145 to 7       139/150
(92 %)
0 diff
(100 %id)
BM849653 stomach .f-u 725 to 1098 1 to 374       374/374
(100 %)
0 diff
(100 %id)
W38749 parathyroid gland, parathyroid tumor .f-u 729 to 1083 1 to 368       368/447
(82 %)
22 diff
(95.1 %id)
CB133884 Liver .f-u 734 to 1353 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BQ292495 amnion_normal .f-u 752 to 1110 1 to 360       360/371
(97 %)
10 diff
(97.4 %id)
BE565590 bladder, carcinoma, cell line .f-u 761 to 1371 1 to 611       611/717
(85 %)
12 diff
(98.4 %id)
CV571542 cornea, eye .f-u 762 to 1325 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BE018642 cervix .f-u 777 to 1300 1 to 524       524/524
(100 %)
0 diff
(100 %id)
BM844778 lymph node, stomach .f-u 778 to 1266 1 to 489       489/489
(100 %)
0 diff
(100 %id)
AA046853 heart .f-u 787 to 1266 1 to 474   fully sequenced,   474/474
(100 %)
0 diff
(100 %id)
BM783597 stomach .f-u 788 to 1463 1 to 674       674/674
(100 %)
2 diff
(99.8 %id)
BG497657 adenocarcinoma, Prostate .f-u 796 to 1580 1 to 779       779/813
(95 %)
28 diff
(96.6 %id)
AA385050 thyroid gland .f-u 797 to 1062 1 to 266       266/266
(100 %)
0 diff
(100 %id)
FN119821 breast carcinoma .f-u 814 to 925 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
W60935 heart .f-u 816 to 1329 1 to 518   fully sequenced,   518/518
(100 %)
14 diff
(97.3 %id)
BE180509 head_neck .f-u 821 to 1170 1 to 348       348/348
(100 %)
5 diff
(98.6 %id)
BE180614 head_neck .f-u 833 to 1170 1 to 335       335/335
(100 %)
6 diff
(98.3 %id)
AL045790 testis .f-u 834 to 1402 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM822440 stomach .f-u 838 to 1412 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BM770106 Ascites, stomach .f-u 849 to 1489 1 to 641       641/641
(100 %)
0 diff
(100 %id)
W21050 lung .f-u 856 to 1274 1 to 428   fully sequenced,   428/428
(100 %)
5 diff
(98.9 %id)
CB123139 Liver .f-u 856 to 1284 1 to 429       429/429
(100 %)
0 diff
(100 %id)
FN129638 breast carcinoma .f-u 868 to 933 1 to 65       65/66
(98 %)
3 diff
(95.5 %id)
TI_149302607   .f-u 870 to 1707 884 to 58   AAA   827/957
(86 %)
17 diff
(98.3 %id)
TI_149311668   .f-u 870 to 1707 906 to 82   AAA   825/945
(87 %)
15 diff
(98.5 %id)
BQ082909 stomach .f-u 882 to 1331 1 to 450       450/450
(100 %)
0 diff
(100 %id)
DA832661 placenta .f-u 886 to 1678 2 to 801   fully sequenced, capped   800/800
(100 %)
16 diff
(98.0 %id)
BM841749 lymph node, stomach .f-u 913 to 1568 1 to 656       656/656
(100 %)
3 diff
(99.6 %id)
BE541917 cervix .f-u 914 to 1617 1 to 702       702/864
(81 %)
20 diff
(97.7 %id)
BM840036 lymph node, stomach .f-u 916 to 1435 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
BE693303 breast .f-u 919 to 1469 10 to 558       549/558
(98 %)
6 diff
(99.0 %id)
AW139374   .f-u 924 to 1407 495 to 12   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 484/484
(100 %)
1 diff
(99.8 %id)
BE564698 bladder, carcinoma, cell line .f-u 926 to 1538 1 to 599       599/732
(81 %)
21 diff
(97.2 %id)
BE379602 bladder, carcinoma, cell line .f-u 935 to 1630 724 to 1       724/728
(99 %)
19 diff
(97.4 %id)
BP271710   .f-u 941 to 1495 1 to 555       555/555
(100 %)
7 diff
(98.8 %id)
FN156641 breast carcinoma .f-u 942 to 1023 1 to 83       83/83
(100 %)
4 diff
(95.2 %id)
CB851506 lung, Primary Lung Cystic Fibrosis EpithelialCells .f-u 954 to 1707 767 to 16   AAA   752/752
(100 %)
2 diff
(99.8 %id)
AA173597   .f-u 971 to 1277 1 to 315   fully sequenced,   315/315
(100 %)
0 diff
(100 %id)
BM818278 stomach .f-u 972 to 1435 1 to 463       463/463
(100 %)
3 diff
(99.4 %id)
BI094378 cervix .f-u 983 to 1620 1 to 638       638/638
(100 %)
5 diff
(99.3 %id)
FN120487 breast carcinoma .f-u 990 to 1078 1 to 86       86/88
(97 %)
4 diff
(95.5 %id)
FN170870 breast carcinoma .f-u 994 to 1080 1 to 85       85/89
(95 %)
3 diff
(96.7 %id)
TI_149282077   .f-u 996 to 1707 803 to 93   AAA   711/711
(100 %)
6 diff
(99.2 %id)
BG254223 adenocarcinoma, cell line, Prostate .f-u 1004 to 1111 715 to 822 L35F L36T L37S I38N I39Y ...     770/978
(78 %)
44 diff
(95.6 %id)
BI260755 cervical carcinoma cell line, cervix .f-u 1010 to 1661 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
BM983571 lung .f-u 1018 to 1707 706 to 17   AAA   690/690
(100 %)
3 diff
(99.6 %id)
TI_149280144   .f-u 1022 to 1707 790 to 105   AAA   686/687
(99 %)
18 diff
(97.4 %id)
BF208582 bladder, carcinoma, cell line .f-u 1023 to 1700 1 to 667       667/790
(84 %)
24 diff
(97.0 %id)
BF846064 lung_normal .f-u 1028 to 1413 1 to 385       385/397
(96 %)
6 diff
(98.5 %id)
BF084495 colon .f-u 1032 to 1312 1 to 280       280/280
(100 %)
15 diff
(94.7 %id)
FN155614 breast carcinoma .f-u 1032 to 1127 1 to 96       96/101
(95 %)
1 diff
(99.1 %id)
BF084532 colon .f-u 1034 to 1326 4 to 290       287/290
(98 %)
6 diff
(98.0 %id)
BF084499 colon .f-u 1036 to 1333 8 to 305       298/305
(97 %)
6 diff
(98.1 %id)
BE714252 head_neck .f-u 1039 to 1410 19 to 390       372/390
(95 %)
6 diff
(98.5 %id)
BE768938 prostate_tumor .f-u 1039 to 1326 19 to 308       290/308
(94 %)
6 diff
(98.1 %id)
BF084575 colon .f-u 1039 to 1326 11 to 295       285/295
(96 %)
6 diff
(98.0 %id)
BF084417 colon .f-u 1041 to 1326 6 to 290       285/290
(98 %)
10 diff
(96.6 %id)
BF084427 colon .f-u 1041 to 1333 16 to 305       290/311
(93 %)
5 diff
(98.4 %id)
BF084606 colon .f-u 1041 to 1326 1 to 286       286/286
(100 %)
8 diff
(97.3 %id)
BQ318444 colon .f-u 1041 to 1326 1 to 279       279/279
(100 %)
18 diff
(93.6 %id)
BQ318470 colon .f-u 1041 to 1326 1 to 282       282/282
(100 %)
10 diff
(96.5 %id)
BQ318557 colon .f-u 1041 to 1326 12 to 294       283/294
(96 %)
6 diff
(98.0 %id)
BF084456 colon .f-u 1042 to 1326 1 to 284       284/284
(100 %)
7 diff
(97.6 %id)
BQ318456 colon .f-u 1042 to 1326 1 to 280       280/280
(100 %)
7 diff
(97.5 %id)
TI_149306142   .f-u 1043 to 1707 757 to 93   AAA   665/989
(67 %)
1 diff
(99.9 %id)
BU686216 lung, Primary Lung Epithelial Cells .f-u 1043 to 1707 683 to 19   AAA   665/673
(98 %)
1 diff
(99.9 %id)
BF084490 colon .f-u 1044 to 1326 18 to 298       281/298
(94 %)
6 diff
(98.0 %id)
BF336532 colon .f-u 1044 to 1326 1 to 282       282/282
(100 %)
11 diff
(96.1 %id)
BF084407 colon .f-u 1045 to 1326 1 to 276       276/276
(100 %)
11 diff
(96.1 %id)
BF084494 colon .f-u 1046 to 1326 1 to 281       281/281
(100 %)
4 diff
(98.6 %id)
BQ318555 colon .f-u 1046 to 1326 1 to 276       276/276
(100 %)
9 diff
(96.8 %id)
BF084414 colon .f-u 1047 to 1326 1 to 279       279/279
(100 %)
2 diff
(99.3 %id)
BF084421 colon .f-u 1047 to 1326 1 to 280       280/280
(100 %)
5 diff
(98.3 %id)
BF084479 colon .f-u 1048 to 1326 15 to 290       276/290
(95 %)
6 diff
(98.0 %id)
BF084493 colon .f-u 1048 to 1326 1 to 276       276/276
(100 %)
18 diff
(93.5 %id)
BF084571 colon .f-u 1048 to 1326 1 to 277       277/277
(100 %)
6 diff
(97.9 %id)
BQ318547 colon .f-u 1048 to 1326 1 to 280       280/280
(100 %)
9 diff
(96.8 %id)
BE769039 prostate_tumor .f-u 1049 to 1326 1 to 275       275/275
(100 %)
3 diff
(99.0 %id)
BF084418 colon .f-u 1049 to 1326 1 to 278       278/278
(100 %)
2 diff
(99.3 %id)
BF084491 colon .f-u 1049 to 1308 1 to 260       260/260
(100 %)
1 diff
(99.7 %id)
BF336503 colon .f-u 1049 to 1173 1 to 125       125/125
(100 %)
4 diff
(96.8 %id)
BF084462 colon .f-u 1051 to 1326 1 to 280       280/280
(100 %)
10 diff
(96.5 %id)
BE768962 prostate_tumor .f-u 1052 to 1410 1 to 359       359/359
(100 %)
7 diff
(98.1 %id)
BF084572 colon .f-u 1052 to 1326 7 to 279       273/279
(97 %)
9 diff
(96.8 %id)
BQ318462 colon .f-u 1053 to 1326 1 to 273       273/273
(100 %)
8 diff
(97.1 %id)
BE707110 head_neck .f-u 1056 to 1246 12 to 201       190/201
(94 %)
6 diff
(97.1 %id)
BE768977 prostate_tumor .f-u 1056 to 1502 1 to 446       446/448
(99 %)
23 diff
(94.9 %id)
BG618576 Liver .f-u 1057 to 1611 1 to 555       555/790
(70 %)
1 diff
(99.9 %id)
BE768968 prostate_tumor .f-u 1060 to 1326 5 to 272       268/272
(98 %)
6 diff
(97.8 %id)
BQ318469 colon .f-u 1060 to 1326 1 to 266       266/266
(100 %)
8 diff
(97.0 %id)
BQ318549 colon .f-u 1062 to 1326 1 to 268       268/268
(100 %)
6 diff
(97.8 %id)
AA384466 thyroid gland .f-u 1068 to 1346 1 to 279       279/280
(99 %)
4 diff
(98.6 %id)
BQ631354 Pancreas, Purified pancreatic islet .f-u 1069 to 1709 641 to 1   tiling clone,   641/641
(100 %)
0 diff
(100 %id)
BQ318556 colon .f-u 1071 to 1333 7 to 265       259/271
(95 %)
16 diff
(94.1 %id)
BQ614111 insulinoma, Pancreas .f-u 1078 to 1707 644 to 15   AAA   630/630
(100 %)
0 diff
(100 %id)
BM855307 stomach .f-u 1079 to 1341 1 to 263       263/263
(100 %)
1 diff
(99.7 %id)
CB120851 cervix, Uterine .f-u 1081 to 1707 1 to 627   AAA   627/627
(100 %)
0 diff
(100 %id)
TI_154010266   .f-u 1083 to 1707 731 to 105   AAA   627/1014
(61 %)
11 diff
(99.0 %id)
BM980769 lung, Primary Lung Cystic Fibrosis EpithelialCells .f-u 1106 to 1707 618 to 17   AAA   602/602
(100 %)
0 diff
(100 %id)
FN095592 breast carcinoma .f-u 1127 to 1235 1 to 110       110/110
(100 %)
1 diff
(99.1 %id)
AA493636 thyroid .f-u 1132 to 1577 8 to 453       446/453
(98 %)
6 diff
(98.7 %id)
FN160694 breast carcinoma .f-u 1138 to 1249 1 to 108       108/108
(100 %)
6 diff
(94.5 %id)
CA502871 Human Lung Epithelial cells, lung .f-u 1146 to 1707 578 to 17   AAA   562/565
(99 %)
3 diff
(99.5 %id)
BF082915 colon_ins .f-u 1148 to 1539 8 to 401       394/401
(98 %)
6 diff
(98.6 %id)
BX435248 brain, fetal brain .f-u 1148 to 1703 564 to 6       559/592
(94 %)
0 diff
(100 %id)
TI_149284719   .f-u 1152 to 1707 627 to 72   AAA   556/1079
(51 %)
3 diff
(99.8 %id)
BM984514 lung, Primary Lung Epithelial Cells .f-u 1152 to 1707 572 to 17   AAA   556/558
(99 %)
3 diff
(99.5 %id)
FN058482 breast carcinoma .f-u 1155 to 1243 1 to 89       89/90
(98 %)
3 diff
(96.7 %id)
BG254687 adenocarcinoma, cell line, Prostate .f-u 1165 to 1709 1 to 546       546/560
(97 %)
4 diff
(99.3 %id)
AW170087 cervix, tumor .f-u 1168 to 1708 541 to 1       541/541
(100 %)
0 diff
(100 %id)
AI091603 parathyroid gland, parathyroid tumor .f-u 1169 to 1709 545 to 5       541/545
(99 %)
0 diff
(100 %id)
AW340447 pooled .f-u 1169 to 1707 539 to 1       539/539
(100 %)
2 diff
(99.7 %id)
AW579264 denis_drash .f-u 1171 to 1608 1 to 437       437/437
(100 %)
20 diff
(95.5 %id)
AW674405 cervix .f-u 1173 to 1708 536 to 1       536/536
(100 %)
1 diff
(99.9 %id)
CA435482 lung, Metastatic Chondrosarcoma .f-u 1175 to 1707 549 to 17   AAA   533/533
(100 %)
0 diff
(100 %id)
BF084560 colon .f-u 1177 to 1326 25 to 174       150/174
(86 %)
6 diff
(96.6 %id)
T59263 lung .f-u 1177 to 1683 1 to 515       515/516
(99 %)
19 diff
(96.4 %id)
AI491885 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f-u 1180 to 1707 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
FN161642 breast carcinoma .f-u 1182 to 1289 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
FN102483 breast carcinoma .f-u 1185 to 1262 1 to 78       78/78
(100 %)
1 diff
(98.8 %id)
AA131801 uterus .f-u 1187 to 1707 523 to 1       523/523
(100 %)
7 diff
(98.7 %id)
BM782112 myeloma .f-u 1194 to 1706 1 to 513       513/513
(100 %)
6 diff
(98.9 %id)
AI660614 colon, colonic mucosa from 5 ulcerative colitispatients .f-u 1198 to 1707 533 to 24   AAA   510/510
(100 %)
8 diff
(98.5 %id)
BM838622 lymph node, stomach .f-u 1199 to 1709 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
BM842770 lymph node, stomach .f-u 1199 to 1704 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
FN071026 breast carcinoma .f-u 1204 to 1306 1 to 100       100/101
(99 %)
4 diff
(96.1 %id)
BM841873 lymph node, stomach .f-u 1204 to 1709 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
FN123800 breast carcinoma .f-u 1205 to 1310 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
AL037729 brain .f-u 1206 to 1707 523 to 22   AAA   502/502
(100 %)
0 diff
(100 %id)
AW749702 breast .f-u 1208 to 1606 1 to 405       405/411
(98 %)
24 diff
(94.2 %id)
AI608598 normal gingiva (cell line from primarykeratinocytes) .f-u 1209 to 1707 499 to 1       499/499
(100 %)
0 diff
(100 %id)
AW373410 breast .f-u 1212 to 1595 1 to 384       384/384
(100 %)
7 diff
(98.2 %id)
AA928074 pooled .f-u 1213 to 1708 496 to 1       496/496
(100 %)
0 diff
(100 %id)
AI803402   .f-u 1219 to 1709 494 to 3       492/494
(99 %)
0 diff
(100 %id)
AI624127 adenocarcinoma, Pancreas .f-u 1219 to 1709 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AW440556 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f-u 1220 to 1709 493 to 3       491/493
(99 %)
0 diff
(100 %id)
FN112828 breast carcinoma .f-u 1221 to 1322 1 to 98       98/98
(100 %)
5 diff
(94.9 %id)
AI885528 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f-u 1222 to 1708 487 to 1       487/487
(100 %)
1 diff
(99.8 %id)
AI418267 pooled .f-u 1224 to 1706 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
AI800279 Kidney .f-u 1226 to 1707 492 to 11   AAA   482/482
(100 %)
0 diff
(100 %id)
AW275960 lung, two pooled squamous cell carcinomas .f-u 1230 to 1709 485 to 6       480/485
(98 %)
0 diff
(100 %id)
AW780300 colon, moderately-differentiated adenocarcinoma .f-u 1230 to 1707 478 to 1       478/478
(100 %)
0 diff
(100 %id)
AA046815 heart .f-u 1236 to 1707 471 to 1   fully sequenced,   471/471
(100 %)
0 diff
(100 %id)
AI493121 Kidney .f-u 1238 to 1707 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI018145 pooled .f-u 1240 to 1709 470 to 1       470/470
(100 %)
0 diff
(100 %id)
FN105472 breast carcinoma .f-u 1243 to 1331 1 to 90       90/96
(93 %)
6 diff
(93.8 %id)
N95222 lung .f-u 1244 to 1708 460 to 1   fully sequenced,   460/460
(100 %)
3 diff
(99.4 %id)
AA877591 colon, colon tumor RER+ .f-u 1244 to 1708 466 to 1       466/466
(100 %)
19 diff
(96.0 %id)
AA969373 pooled .f-u 1245 to 1709 466 to 2       465/466
(99 %)
0 diff
(100 %id)
AW130864 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f-u 1246 to 1709 466 to 3       464/466
(99 %)
0 diff
(100 %id)
AA173971   .f-u 1247 to 1709 463 to 1   fully sequenced,   463/463
(100 %)
0 diff
(100 %id)
AI561113 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f-u 1247 to 1707 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AA682266 liver and spleen .f-u 1250 to 1707 474 to 18   AAA   457/457
(100 %)
4 diff
(99.2 %id)
AA580219 breast .f-u 1250 to 1709 460 to 1       460/460
(100 %)
0 diff
(100 %id)
BE542577 cervix .f-u 1250 to 1709 1 to 455       455/457
(99 %)
7 diff
(98.5 %id)
AW612944 colon, moderately-differentiated adenocarcinoma .f-u 1258 to 1707 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI624003 adenocarcinoma, Pancreas .f-u 1265 to 1709 447 to 3       445/447
(99 %)
0 diff
(100 %id)
AI805412 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f-u 1265 to 1707 443 to 1       443/443
(100 %)
0 diff
(100 %id)
FN052134 breast carcinoma .f-u 1270 to 1361 1 to 92       92/93
(98 %)
2 diff
(97.9 %id)
AI570951 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f-u 1270 to 1707 438 to 1       438/438
(100 %)
1 diff
(99.8 %id)
AI683016 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f-u 1271 to 1707 448 to 13   AAA   436/436
(100 %)
1 diff
(99.8 %id)
AI309126 2 pooled tumors (clear cell type), Kidney .f-u 1272 to 1709 439 to 2       438/439
(99 %)
0 diff
(100 %id)
AI566235 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f-u 1272 to 1706 435 to 2       434/435
(99 %)
0 diff
(100 %id)
AW007263 adenocarcinoma, Pancreas .f-u 1272 to 1709 440 to 3       438/440
(99 %)
0 diff
(100 %id)
AW338522 adenocarcinoma, Pancreas .f-u 1272 to 1708 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AI923647 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f-u 1273 to 1708 436 to 1       436/436
(100 %)
0 diff
(100 %id)
T24451   .f-u 1283 to 1402 1 to 120       120/120
(100 %)
0 diff
(100 %id)
AA772541 parathyroid gland, parathyroid tumor .f-u 1284 to 1709 431 to 6       426/431
(98 %)
0 diff
(100 %id)
FN067099 breast carcinoma .f-u 1285 to 1348 1 to 62       62/62
(100 %)
2 diff
(96.8 %id)
DB378954 placenta .f-u 1285 to 1707 421 to 1   fully sequenced,   421/421
(100 %)
3 diff
(99.3 %id)
AW235160 pooled germ cell tumors .f-u 1291 to 1707 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
AI796153 Kidney .f-u 1292 to 1703 414 to 3       412/414
(99 %)
0 diff
(100 %id)
AW002899 pooled germ cell tumors .f-u 1293 to 1707 416 to 1       416/416
(100 %)
3 diff
(99.3 %id)
AW197566 pooled germ cell tumors .f-u 1293 to 1708 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AI270322 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1294 to 1707 428 to 15   AAA   414/414
(100 %)
0 diff
(100 %id)
AI433931 adenocarcinoma, Pancreas .f-u 1296 to 1707 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AI095701 uterus .f-u 1297 to 1705 409 to 1       409/409
(100 %)
0 diff
(100 %id)
H51475 brain .f-u 1298 to 1470 1 to 173   fully sequenced,   173/173
(100 %)
0 diff
(100 %id)
AW070899 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .f-u 1298 to 1707 410 to 1       410/410
(100 %)
0 diff
(100 %id)
W60870 heart .f-u 1299 to 1709 419 to 1   fully sequenced,   419/419
(100 %)
8 diff
(98.1 %id)
CB049901 Prostate .f-u 1302 to 1377 2 to 77   fully sequenced,   76/77
(98 %)
5 diff
(93.6 %id)
BP371495 testis .f-u 1302 to 1707 1 to 406   AAA   406/406
(100 %)
0 diff
(100 %id)
BE073128 breast .f-u 1304 to 1618 34 to 347       314/347
(90 %)
6 diff
(98.3 %id)
AI373485 Kidney .f-u 1307 to 1708 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AW473207 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f-u 1307 to 1707 412 to 12   AAA   401/401
(100 %)
0 diff
(100 %id)
AI207375 placenta .f-u 1310 to 1707 411 to 14   AAA   398/398
(100 %)
0 diff
(100 %id)
AI619939 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f-u 1310 to 1707 398 to 1       398/398
(100 %)
0 diff
(100 %id)
AW007314 adenocarcinoma, Pancreas .f-u 1310 to 1709 402 to 3       400/402
(99 %)
0 diff
(100 %id)
BM838692 lymph node, stomach .f-u 1318 to 1654 1 to 335       335/335
(100 %)
3 diff
(99.2 %id)
AW005479 colon .f-u 1322 to 1707 412 to 27   AAA   386/386
(100 %)
3 diff
(99.3 %id)
BG255403 adenocarcinoma, cell line, Prostate .f-u 1325 to 1706 1 to 388       388/412
(94 %)
21 diff
(95.0 %id)
BE537295 cervix .f-u 1326 to 1703 1 to 379       379/379
(100 %)
1 diff
(99.8 %id)
CA435572 lung, Metastatic Chondrosarcoma .f-u 1328 to 1709 396 to 17       380/396
(95 %)
0 diff
(100 %id)
AW150676 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1333 to 1707 375 to 1       375/375
(100 %)
0 diff
(100 %id)
N92626 parathyroid gland, parathyroid tumor .f-u 1335 to 1709 374 to 5       370/436
(84 %)
0 diff
(100 %id)
AI358673 adenocarcinoma, Pancreas .f-u 1336 to 1706 371 to 1       371/371
(100 %)
0 diff
(100 %id)
R51097 whole brain .f-u 1337 to 1707 390 to 14   AAA   377/377
(100 %)
10 diff
(97.4 %id)
AA583406 germ cell tumor .f-u 1338 to 1706 369 to 1       369/369
(100 %)
0 diff
(100 %id)
AI446451 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1338 to 1708 371 to 1       371/371
(100 %)
0 diff
(100 %id)
BX098100 whole brain .f-u 1339 to 1705 385 to 18       368/385
(95 %)
0 diff
(100 %id)
CB049900 Prostate .f-u 1347 to 1707 414 to 54   fully sequenced, AAA   361/361
(100 %)
0 diff
(100 %id)
AA366854 Pancreas .f-u 1348 to 1676 1 to 332       332/333
(99 %)
5 diff
(98.5 %id)
BM827084 Ascites, stomach .f-u 1348 to 1655 1 to 308       308/308
(100 %)
2 diff
(99.4 %id)
AW593971 pooled germ cell tumors .f-u 1353 to 1702 357 to 8       350/357
(98 %)
0 diff
(100 %id)
AI420805 Prostate .f-u 1354 to 1707 380 to 27   AAA   354/354
(100 %)
0 diff
(100 %id)
AI804725 Prostate .f-u 1354 to 1707 368 to 15   AAA   354/354
(100 %)
1 diff
(99.8 %id)
AI698877 colon .f-u 1354 to 1709 356 to 1       356/356
(100 %)
2 diff
(99.5 %id)
AI273874 ovary, tumor, 5 pooled (see description) .f-u 1355 to 1709 357 to 3       355/357
(99 %)
0 diff
(100 %id)
BF834646 head_neck .f-u 1364 to 1605 1 to 240       240/251
(95 %)
9 diff
(96.5 %id)
TI_149276140   .f-u 1364 to 1707 427 to 84   AAA   344/967
(35 %)
6 diff
(99.4 %id)
BM968905 lung, Primary Lung Epithelial Cells .f-u 1364 to 1707 360 to 17   AAA   344/358
(96 %)
6 diff
(98.4 %id)
FN054573 breast carcinoma .f-u 1366 to 1485 1 to 120       120/120
(100 %)
0 diff
(100 %id)
AI299330 carcinoid, lung .f-u 1368 to 1707 368 to 29   AAA   340/340
(100 %)
11 diff
(96.8 %id)
CV573752 cornea, eye .f-u 1370 to 1707 1 to 338   AAA   338/338
(100 %)
0 diff
(100 %id)
CB243582 Human Lung Epithelial cells, lung .f-u 1372 to 1707 352 to 17   AAA   336/359
(93 %)
1 diff
(99.8 %id)
BM768707 stomach .f-u 1375 to 1707 1 to 333   AAA   333/333
(100 %)
0 diff
(100 %id)
AA781566 parathyroid gland, parathyroid tumor .f-u 1377 to 1709 337 to 5       333/337
(98 %)
0 diff
(100 %id)
AA453868 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1381 to 1694 1 to 314       314/314
(100 %)
0 diff
(100 %id)
AI027365 parathyroid gland, parathyroid tumor .f-u 1383 to 1707 342 to 19   AAA   324/324
(100 %)
1 diff
(99.7 %id)
AI470263 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1391 to 1707 317 to 1       317/317
(100 %)
0 diff
(100 %id)
AA583160 germ cell tumor .f-u 1392 to 1704 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AI570355 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1393 to 1707 328 to 14   AAA   315/315
(100 %)
10 diff
(96.9 %id)
AI783967 ovary, tumor, 5 pooled (see description) .f-u 1393 to 1708 320 to 1       320/320
(100 %)
7 diff
(97.9 %id)
AI671365 Kidney .f-u 1393 to 1707 315 to 1       315/315
(100 %)
0 diff
(100 %id)
CA435067 lung, Lung Focal Fibrosis .f-u 1398 to 1707 327 to 19   AAA   309/550
(56 %)
3 diff
(99.5 %id)
AI201520 Prostate .f-u 1401 to 1707 307 to 1       307/307
(100 %)
0 diff
(100 %id)
BU932321 mixed (pool of 40 RNAs) .f-u 1404 to 1709 1 to 304       304/1045
(29 %)
3 diff
(99.8 %id)
T23534   .f-u 1412 to 1709 299 to 2       298/299
(99 %)
0 diff
(100 %id)
CB957334 Pooled-Glandular .f-u 1418 to 1707 1 to 290       290/291
(99 %)
2 diff
(99.4 %id)
AA909197 pooled .f-u 1426 to 1707 282 to 1       282/285
(98 %)
0 diff
(100 %id)
H85051 eye, retina .f-u 1428 to 1697 273 to 1       273/273
(100 %)
3 diff
(99.0 %id)
FN079243 breast carcinoma .f-u 1436 to 1520 1 to 81       81/82
(98 %)
5 diff
(94.0 %id)
H51433 brain .f-u 1440 to 1656 228 to 1   fully sequenced,   228/228
(100 %)
6 diff
(97.4 %id)
FN120850 breast carcinoma .f-u 1443 to 1547 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
AI198729 lung .f-u 1454 to 1707 254 to 1       254/254
(100 %)
0 diff
(100 %id)
AW079725 esophagus, squamous cell carcinoma .f-u 1454 to 1708 255 to 1       255/255
(100 %)
0 diff
(100 %id)
AI824707 adenocarcinoma, Pancreas .f-u 1456 to 1708 255 to 1       255/255
(100 %)
1 diff
(99.7 %id)
FN098329 breast carcinoma .f-u 1457 to 1518 1 to 62       62/63
(98 %)
1 diff
(98.5 %id)
FN073490 breast carcinoma .f-u 1460 to 1558 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
AA740547 2 pooled tumors (clear cell type), Kidney .f-u 1461 to 1709 250 to 2       249/250
(99 %)
0 diff
(100 %id)
R39996 whole brain .f-u 1468 to 1707 263 to 18   AAA   246/246
(100 %)
6 diff
(97.6 %id)
AW014957   .f-u 1469 to 1707 256 to 18   AAA   239/240
(99 %)
1 diff
(99.6 %id)
F04763 brain, total brain .f-u 1473 to 1707 235 to 1       235/235
(100 %)
0 diff
(100 %id)
AA860803 parathyroid gland, parathyroid tumor .f-u 1474 to 1707 245 to 12   AAA   234/234
(100 %)
0 diff
(100 %id)
FN053903 breast carcinoma .f-u 1482 to 1549 1 to 68       68/68
(100 %)
3 diff
(95.6 %id)
FN152608 breast carcinoma .f-u 1485 to 1587 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
AA860673 parathyroid gland, parathyroid tumor .f-u 1486 to 1709 229 to 6       224/229
(97 %)
0 diff
(100 %id)
AI568080 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1487 to 1707 221 to 1       221/221
(100 %)
0 diff
(100 %id)
FN160083 breast carcinoma .f-u 1514 to 1621 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
FN045850 breast carcinoma .f-u 1526 to 1595 1 to 70       70/71
(98 %)
1 diff
(98.6 %id)
H93782.
matches multiple genes
liver and spleen .f-u 1531 to 1687 158 to 1     also hits gene skustorby 158/158
(100 %)
1 diff
(99.4 %id)
AI270565 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1538 to 1707 193 to 24   AAA   170/170
(100 %)
1 diff
(99.5 %id)
EC468837 Prostate .f-u 1544 to 1658 1 to 114       114/114
(100 %)
2 diff
(98.3 %id)
FN122569 breast carcinoma .f-u 1549 to 1659 1 to 108       108/111
(97 %)
7 diff
(93.7 %id)
AA169497   .f-u 1553 to 1709 159 to 3       157/159
(98 %)
0 diff
(100 %id)
FN162133 breast carcinoma .f-u 1567 to 1685 1 to 119       119/119
(100 %)
3 diff
(97.5 %id)
EC480510 Prostate .f-u 1635 to 1709 1 to 74       74/74
(100 %)
1 diff
(98.7 %id)
DA791468 brain .g 1 to 474 2 to 475 exact tiling clone, capped   474/474
(100 %)
0 diff
(100 %id)
BE719343 head_neck Gene MAL2, variant not shown         This clone was ignored    
AV704007 adrenal gland Gene MAL2, variant not shown         Suspected internal deletion, this clone was ignored    
CB113541 Liver Gene MAL2, variant not shown         This clone was ignored    
AK172820   Gene MAL2, variant not shown       available from FLJ, AAA This clone was ignored    
DA430459 colon Gene MAL2, variant not shown       capped This clone was ignored    
AW965573   Gene MAL2, variant not shown         Suspected internal deletion, this clone was ignored    
DA392386 thalamus Gene MAL2, variant not shown       capped This clone was ignored    
BE379942 bladder, carcinoma, cell line Gene MAL2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI